Pyxis Oncology, Inc. (PYXS)
NASDAQ·Healthcare·Biotechnology
$3.22
-4.17%
Mkt Cap $211.61M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$6.50
Range $6.00 – $7.00
Implied Upside
+102.2%
Consensus $6.50 vs current $3.22
NASDAQ·Healthcare·Biotechnology
$3.22
-4.17%
Mkt Cap $211.61M
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$6.50
Range $6.00 – $7.00
+102.2%
Consensus $6.50 vs current $3.22